Effect of Chemotherapeutics and Tocopherols on MCF-7 Breast Adenocarcinoma and KGN Ovarian Carcinoma Cell Lines
Adenocarcinoma
/ drug therapy
Antineoplastic Combined Chemotherapy Protocols
/ pharmacology
Apoptosis
/ drug effects
Breast Neoplasms
/ drug therapy
Cell Line, Tumor
Cell Survival
/ drug effects
Doxorubicin
/ pharmacology
Female
Humans
MCF-7 Cells
Ovarian Neoplasms
/ drug therapy
alpha-Tocopherol
/ pharmacology
Journal
BioMed research international
ISSN: 2314-6141
Titre abrégé: Biomed Res Int
Pays: United States
ID NLM: 101600173
Informations de publication
Date de publication:
2019
2019
Historique:
received:
07
06
2018
revised:
28
11
2018
accepted:
30
12
2018
entrez:
16
2
2019
pubmed:
16
2
2019
medline:
29
5
2019
Statut:
epublish
Résumé
The combination of doxorubicin and cyclophosphamide commonly used to treat breast cancer can cause premature ovarian failure and infertility.
Identifiants
pubmed: 30766885
doi: 10.1155/2019/6146972
pmc: PMC6350544
doi:
Substances chimiques
Doxorubicin
80168379AG
alpha-Tocopherol
H4N855PNZ1
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
6146972Références
Biochem Pharmacol. 1999 Apr 1;57(7):727-41
pubmed: 10075079
Cancer Treat Rep. 1976 Jul;60(7):961-2
pubmed: 1009530
Biol Reprod. 1999 Jun;60(6):1446-52
pubmed: 10330104
Ann Clin Biochem. 1999 Mar;36 ( Pt 2):216-20
pubmed: 10370740
FASEB J. 1999 Jul;13(10):1145-55
pubmed: 10385606
Hum Reprod. 1999 Jul;14(7):1903-7
pubmed: 10402415
Biol Pharm Bull. 1999 Jul;22(7):698-702
pubmed: 10443465
Endocrinology. 1999 Dec;140(12):5789-96
pubmed: 10579345
J Biol Chem. 2000 Jun 30;275(26):20204-9
pubmed: 10777507
Clin Pharmacokinet. 2000 Apr;38(4):291-304
pubmed: 10803453
Cancer Invest. 2000;18(6):521-9
pubmed: 10923100
Endocrinology. 2001 Jan;142(1):437-45
pubmed: 11145608
Cancer Res. 1975 Jun;35(6):1568-73
pubmed: 1131824
Biol Reprod. 2001 Jun;64(6):1755-60
pubmed: 11369605
Br J Cancer. 1975 Aug;32(2):199-207
pubmed: 1212350
Am J Clin Nutr. 2002 Oct;76(4):703-16
pubmed: 12324281
Anticancer Drugs. 2003 Mar;14(3):239-46
pubmed: 12634619
J Clin Oncol. 2003 Mar 15;21(6):968-75
pubmed: 12637459
J Clin Oncol. 2003 Nov 15;21(22):4184-93
pubmed: 14615446
Aust N Z J Obstet Gynaecol. 2004 Feb;44(1):6-9
pubmed: 15089860
Ann N Y Acad Sci. 2004 Dec;1031:399-400
pubmed: 15753180
Clin Pharmacokinet. 2005;44(11):1135-64
pubmed: 16231966
Toxicol Sci. 2006 Apr;90(2):500-9
pubmed: 16381661
Am J Med. 2005 Dec 19;118 Suppl 12B:136-41
pubmed: 16414339
BMC Cancer. 2006 Jan 17;6:13
pubmed: 16417629
Cell Death Differ. 2006 Sep;13(9):1466-74
pubmed: 16439991
Breast Dis. 2005-2006;23:103-13
pubmed: 16823173
J Clin Oncol. 2006 Dec 1;24(34):5381-7
pubmed: 17135639
Cancer Epidemiol Biomarkers Prev. 2007 Mar;16(3):566-71
pubmed: 17372253
Annu Rev Nutr. 2007;27:347-62
pubmed: 17439363
Free Radic Biol Med. 2007 Jul 1;43(1):4-15
pubmed: 17561088
Toxicol In Vitro. 2008 Feb;22(1):232-9
pubmed: 17904330
Cancer. 2007 Nov 15;110(10):2222-9
pubmed: 17932880
Biotechnol Appl Biochem. 2008 Oct;51(Pt 2):63-71
pubmed: 18171324
Clin Cancer Res. 2009 Jun 15;15(12):4242-9
pubmed: 19509159
Nat Rev Clin Oncol. 2009 Nov;6(11):638-47
pubmed: 19786984
Carcinogenesis. 2010 Apr;31(4):687-94
pubmed: 20097733
Br J Cancer. 2010 Mar 16;102(6):1003-9
pubmed: 20179710
Reprod Biol Endocrinol. 2010 Mar 04;8:20
pubmed: 20202194
Clin Pharmacokinet. 1991 Mar;20(3):194-208
pubmed: 2025981
Gynecol Oncol. 2010 Jul;118(1):69-75
pubmed: 20417958
Clin Obstet Gynecol. 2010 Dec;53(4):727-39
pubmed: 21048440
Pharmacogenet Genomics. 2011 Jul;21(7):440-6
pubmed: 21048526
Cancer Prev Res (Phila). 2011 Mar;4(3):404-13
pubmed: 21372040
Toxicol Appl Pharmacol. 2011 Jun 1;253(2):94-102
pubmed: 21439308
Indian J Physiol Pharmacol. 1990 Apr;34(2):94-100
pubmed: 2174831
Aging (Albany NY). 2011 Aug;3(8):782-93
pubmed: 21869459
J Lipid Res. 2011 Dec;52(12):2111-35
pubmed: 21976778
JAMA. 2011 Oct 12;306(14):1549-56
pubmed: 21990298
Curr Oncol. 2011 Dec;18(6):e288-96
pubmed: 22184496
Nutrients. 2011 Nov;3(11):962-86
pubmed: 22254089
Hum Reprod Update. 2012 Sep-Oct;18(5):525-35
pubmed: 22647504
PLoS One. 2012;7(8):e42293
pubmed: 22876313
World J Surg. 2014 Sep;38(9):2288-96
pubmed: 24700093
Int J Cancer. 2015 Mar 1;136(5):E359-86
pubmed: 25220842
Toxicon. 2015 Nov;106:79-88
pubmed: 26403865
Hum Reprod. 2015 Dec;30(12):2926-35
pubmed: 26466914
Cancer Prev Res (Phila). 2017 Mar;10(3):188-197
pubmed: 28096236
Breast Cancer Res Treat. 2017 Aug;164(3):649-658
pubmed: 28508185
Cancer Res. 1987 May 15;47(10):2723-6
pubmed: 3552204
Cancer Chemother Pharmacol. 1986;17(3):223-6
pubmed: 3742706
Clin Pharmacokinet. 1979 Sep-Oct;4(5):380-94
pubmed: 389529
Am Heart J. 1986 Jan;111(1):95-102
pubmed: 3946165
Res Commun Chem Pathol Pharmacol. 1979 May;24(2):401-4
pubmed: 461995
Am J Hosp Pharm. 1979 Nov;36(11):1536-8
pubmed: 517541
Am J Pediatr Hematol Oncol. 1979 Summer;1(2):151-3
pubmed: 543510
Science. 1984 Oct 26;226(4673):466-8
pubmed: 6093249
Lab Invest. 1983 Jul;49(1):69-77
pubmed: 6408310
Cancer Res. 1983 Sep;43(9):3998-4006
pubmed: 6871841
J Exp Med. 1982 Jan 1;155(1):276-90
pubmed: 6976414
Ann Intern Med. 1982 Feb;96(2):133-9
pubmed: 7059060
J Natl Cancer Inst. 1994 Nov 2;86(21):1645-8
pubmed: 7932830
J Natl Cancer Inst Monogr. 1994;(16):191-7
pubmed: 7999464
Proc Natl Acad Sci U S A. 1995 Dec 19;92(26):12170-4
pubmed: 8618865
Cancer Chemother Pharmacol. 1996;38(6):553-60
pubmed: 8823498
Nat Med. 1997 Nov;3(11):1228-32
pubmed: 9359697
J Clin Oncol. 1998 Feb;16(2):501-14
pubmed: 9469334
J Natl Cancer Inst. 1998 Mar 18;90(6):440-6
pubmed: 9521168